Substrate Recognition of a tRNA Modifying Enzyme
tRNA 修饰酶的底物识别
基本信息
- 批准号:7104456
- 负责人:
- 金额:$ 27.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-08-01 至 2008-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Queuine (one of ca. 100 naturally occurring modified bases) is found in the wobble position (34) of 4 tRNAs (anticodons GUN) in eubacteria and eukaryotes. It is introduced into tRNAs by a post-transcriptional base exchange catalyzed by tRNA-guanine transglycosylase (TGT, also conserved across the kingdoms).. It has been shown that TGT is required for pathogenicity of the dysentery-causing bacterium Shigella flexneri. While the tgt gene has been shown not to be required for growth in cell culture, the relationship between tgt and pathogenicity is not understood, and the present data suggest that TGT could be a novel antibiotic target. Previous studies have elucidated many aspects of the molecular basis of the recognition and discrimination of specific tRNAs and heterocyclic substrates by the eubacterial TGT. However, much work still needs to be done to understand the differential properties of eukaryotic vs. eubacterial TGTs. Other than correlations with proliferation, differentiation, retroviral frameshifting, and bacterial virulence, little is known about the physiological roles of queuine let alone how these roles are carried out. There are two overarching goals of this proposal. The first is to elucidate the similarities and differences between the eubacterial TGT and the human TGT. These studies are prerequisite to the rational design of selective inhibitors of the eubacterial TGT. Our second overarching goal is to try to elucidate the physiological role(s) of queuine in eubacteria and eukaryotes. Given the potential of TGT as a novel antibiotic target, it is important to understand the physiological role(s) of queuine and any differences between human and eubacteria. In order to achieve these goals, we have proposed a number of specific aims that bring many techniques and approaches (e.g., molecular biology, enzymology, crystallography, computational chemistry, synthetic chemistry, genomics, and proteomics) to bear on this problem. To carry out these studies in a rigorous fashion, we have established collaborations with key experts and take advantage of the resources available here at the University of Michigan. A clear understanding of the similarities and differences between the TGTs from eubacteria and human will be of significance for many reasons but most obviously for the future design of novel antibiotics.
描述(由申请人提供):Queuine(约 100 个天然存在的修饰碱基之一)发现于真细菌和真核生物中 4 个 tRNA(反密码子 GUN)的摆动位置(34)中。它通过 tRNA-鸟嘌呤转糖基酶(TGT,在各个王国中也保守)催化的转录后碱基交换引入 tRNA。研究表明,TGT 是引起痢疾的福氏志贺氏菌的致病性所必需的。虽然 tgt 基因已被证明不是细胞培养物中生长所必需的,但 tgt 和致病性之间的关系尚不清楚,目前的数据表明 TGT 可能是一种新的抗生素靶点。先前的研究已经阐明了真细菌 TGT 识别和区分特定 tRNA 和杂环底物的分子基础的许多方面。然而,仍然需要做很多工作来了解真核 TGT 与真细菌 TGT 的差异特性。 除了与增殖、分化、逆转录病毒移码和细菌毒力的相关性之外,人们对队列的生理作用知之甚少,更不用说这些作用是如何发挥的了。该提案有两个总体目标。首先是阐明真细菌TGT和人类TGT之间的异同。这些研究是合理设计真细菌 TGT 选择性抑制剂的先决条件。我们的第二个总体目标是尝试阐明奎因在真细菌和真核生物中的生理作用。鉴于 TGT 作为新型抗生素靶点的潜力,了解队列的生理作用以及人类和真细菌之间的差异非常重要。为了实现这些目标,我们提出了许多具体目标,利用许多技术和方法(例如分子生物学、酶学、晶体学、计算化学、合成化学、基因组学和蛋白质组学)来解决这个问题。为了以严格的方式开展这些研究,我们与主要专家建立了合作,并利用密歇根大学的可用资源。出于多种原因,清楚地了解真细菌和人类 TGT 之间的异同具有重要意义,但最明显的是对于未来新型抗生素的设计。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Glutamate versus glutamine exchange swaps substrate selectivity in tRNA-guanine transglycosylase: insight into the regulation of substrate selectivity by kinetic and crystallographic studies.
谷氨酸与谷氨酰胺交换交换 tRNA-鸟嘌呤转糖基酶中的底物选择性:通过动力学和晶体学研究深入了解底物选择性的调节。
- DOI:10.1016/j.jmb.2007.09.062
- 发表时间:2007
- 期刊:
- 影响因子:5.6
- 作者:Tidten,Naomi;Stengl,Bernhard;Heine,Andreas;Garcia,GeorgeA;Klebe,Gerhard;Reuter,Klaus
- 通讯作者:Reuter,Klaus
Differential heterocyclic substrate recognition by, and pteridine inhibition of E. coli and human tRNA-guanine transglycosylases.
- DOI:10.1016/j.bbrc.2011.05.100
- 发表时间:2011-06-24
- 期刊:
- 影响因子:3.1
- 作者:Thomas, C. Eric;Chen, Yi-Chen;Garcia, George A.
- 通讯作者:Garcia, George A.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
George A Garcia其他文献
George A Garcia的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('George A Garcia', 18)}}的其他基金
Novel Structure-Based Rifamycins for Drug-resistant TB and HIV Co-infection
基于新型结构的利福霉素治疗耐药结核病和艾滋病毒合并感染
- 批准号:
9201300 - 财政年份:2015
- 资助金额:
$ 27.19万 - 项目类别:
Targeting Bacterial Virulence Transcription Factors, a Novel Antibiotic Approach
针对细菌毒力转录因子,一种新的抗生素方法
- 批准号:
7893519 - 财政年份:2010
- 资助金额:
$ 27.19万 - 项目类别:
Targeting Bacterial Virulence Transcription Factors, a Novel Antibiotic Approach
针对细菌毒力转录因子,一种新的抗生素方法
- 批准号:
8134894 - 财政年份:2010
- 资助金额:
$ 27.19万 - 项目类别:
Substrate Recognition of a tRNA Modifying Enzyme
tRNA 修饰酶的底物识别
- 批准号:
6785507 - 财政年份:2003
- 资助金额:
$ 27.19万 - 项目类别:
Substrate Recognition of a tRNA Modifying Enzyme
tRNA 修饰酶的底物识别
- 批准号:
6931595 - 财政年份:2003
- 资助金额:
$ 27.19万 - 项目类别:
Substrate Recognition of a tRNA Modifying Enzyme
tRNA 修饰酶的底物识别
- 批准号:
6574153 - 财政年份:2003
- 资助金额:
$ 27.19万 - 项目类别:
KINETICS AND MECHANISM OF TRNA-QUANINE TRANSGLYCOLASE
TRNA-鸟嘌呤转糖酶的动力学和机制
- 批准号:
3509802 - 财政年份:1991
- 资助金额:
$ 27.19万 - 项目类别:
相似国自然基金
Ryanodine受体RyR1的晶体结构研究
- 批准号:30970572
- 批准年份:2009
- 资助金额:8.0 万元
- 项目类别:面上项目
冷冻干燥技术制备超微粉体中非晶形成与非晶晶化的机理研究
- 批准号:50604001
- 批准年份:2006
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
相似海外基金
CAREER: Unveiling the structure and stability of prenucleation clusters and their roles in crystallization pathway and final crystal structure
职业:揭示成核前团簇的结构和稳定性及其在结晶途径和最终晶体结构中的作用
- 批准号:
2338173 - 财政年份:2024
- 资助金额:
$ 27.19万 - 项目类别:
Continuing Grant
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 27.19万 - 项目类别:
CAREER: Nanoscale Resolution of Near-Interface Crystallization in Multicomponent Semicrystalline Polymeric Materials
职业:多组分半晶聚合物材料中近界面结晶的纳米级分辨率
- 批准号:
2338613 - 财政年份:2024
- 资助金额:
$ 27.19万 - 项目类别:
Continuing Grant
CAREER: Evaluating Theories of Polymer Crystallization by Directly Calculating the Nucleation Barrier in a Polymer Melt
职业:通过直接计算聚合物熔体中的成核势垒来评估聚合物结晶理论
- 批准号:
2338690 - 财政年份:2024
- 资助金额:
$ 27.19万 - 项目类别:
Continuing Grant
Anti-solvent crystallization及び ED-Rプロセスを用いる新規LiB再生システムの構築
采用反溶剂结晶和ED-R工艺构建新型LiB再生系统
- 批准号:
24K08133 - 财政年份:2024
- 资助金额:
$ 27.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Creation of the active fiber-type device by glass crystallization for next-generation light control
通过玻璃结晶创建用于下一代光控制的有源光纤型装置
- 批准号:
22KJ0290 - 财政年份:2023
- 资助金额:
$ 27.19万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Understanding Plant Based Fat Crystallization for the Design of Vegan and Low Carbon Footprint Chocolate
了解植物脂肪结晶在纯素和低碳足迹巧克力设计中的应用
- 批准号:
BB/Y512692/1 - 财政年份:2023
- 资助金额:
$ 27.19万 - 项目类别:
Training Grant
Pilot Studies of PAX3-FOXO1 Fusions Proteins in Alveolar Rhabdomyosarcoma
PAX3-FOXO1 融合蛋白在肺泡横纹肌肉瘤中的初步研究
- 批准号:
10726763 - 财政年份:2023
- 资助金额:
$ 27.19万 - 项目类别:
Mechanisms of structural plasticity, client interactions, and co-aggregation of the lens ⍺-crystallins
晶状体α-晶状体的结构可塑性、客户相互作用和共聚集机制
- 批准号:
10709482 - 财政年份:2023
- 资助金额:
$ 27.19万 - 项目类别:
Bilingualism as a protective factor of ADRD in American Indian adults: the Strong Heart Study
双语是美洲印第安人成人 ADRD 的保护因素:强心脏研究
- 批准号:
10582307 - 财政年份:2023
- 资助金额:
$ 27.19万 - 项目类别:














{{item.name}}会员




